574 related articles for article (PubMed ID: 33762908)
1. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
Yang Y; Li Y; Yang H; Guo J; Li N
Front Mol Neurosci; 2021; 14():631553. PubMed ID: 33762908
[TBL] [Abstract][Full Text] [Related]
2. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang L; Dong Y; Ji H; Shen L
Aging Dis; 2019 Dec; 10(6):1293-1301. PubMed ID: 31788340
[TBL] [Abstract][Full Text] [Related]
3. Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease.
Zhang X; Feng S; Fan Y; Luo Y; Jin L; Li S
Front Neurol; 2020; 11():810. PubMed ID: 32849243
[TBL] [Abstract][Full Text] [Related]
4. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.
Vallelunga A; Ragusa M; Di Mauro S; Iannitti T; Pilleri M; Biundo R; Weis L; Di Pietro C; De Iuliis A; Nicoletti A; Zappia M; Purrello M; Antonini A
Front Cell Neurosci; 2014; 8():156. PubMed ID: 24959119
[TBL] [Abstract][Full Text] [Related]
5. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers.
Zhang M; He P; Bian Z
Front Mol Neurosci; 2021; 14():685143. PubMed ID: 34421536
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
Teixeira Dos Santos MC; Bell R; da Costa AN
Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease.
Roser AE; Caldi Gomes L; Schünemann J; Maass F; Lingor P
Front Neurosci; 2018; 12():625. PubMed ID: 30233304
[TBL] [Abstract][Full Text] [Related]
12. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
[TBL] [Abstract][Full Text] [Related]
13. Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease.
Zhang X; Yang R; Hu BL; Lu P; Zhou LL; He ZY; Wu HM; Zhu JH
Front Cell Neurosci; 2017; 11():170. PubMed ID: 28690499
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
Su L; Wang C; Zheng C; Wei H; Song X
BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
[TBL] [Abstract][Full Text] [Related]
15. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
16. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis.
Ravnik-Glavač M; Glavač D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138249
[TBL] [Abstract][Full Text] [Related]
17. [Research Progress of microRNA-7/124/155 in Parkinson's Disease].
Chen T; Chen H; Yan WH; Zhu MY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):484-492. PubMed ID: 37407538
[TBL] [Abstract][Full Text] [Related]
18. Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker.
Yang Z; Li T; Cui Y; Li S; Cheng C; Shen B; Le W
Front Neurosci; 2019; 13():218. PubMed ID: 30936821
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-221 serves as a biomarker for Parkinson's disease.
Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
[TBL] [Abstract][Full Text] [Related]
20. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
